Differentiated thyroid carcinoma - Clinical presentation, diagnosis and treatment;Therapiekonzept bei differenziertem schilddrüsenkarzinom - Resultate über 25 jahre bei 257 patienten

Praxis

Volumn 89, Issue 44, 2000, Pages 1779-1797

  Gemsenjager E ^a   Heitz, Ph U ^b   Martina, B ^c   Schweizer, I ^a  

^a Chirurgische Klinik Stadtspital Waid   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c KANTONSSPITAL BASEL   (Switzerland)

Author keywords

Capsular dissection; Follicular thyroid carcinoma; Frozen section; Papillary thyroid carcinoma; Selective treatment; TNM prognostic classification

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; LYMPHADENECTOMY; MALE; MIDDLE AGED; MORTALITY; PAPILLARY CARCINOMA; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; THYROID TUMOR; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0034597691     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Ain KB. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1995; 24: 711-60.
2. Grebe SK, Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am 1995; 24: 761-802.
3. Schauer A. Pathogenese und pathologische Anatomie. In: Becker HD, Heinze HG, Herausgeber. Maligne Schilddrüsentumoren. Berlin, Heidelberg: Springer-Verlag; 1984. S. 2-6.
4. Gharib H. Fine-Needle Aspiration Biopsy of Thyroid Nodules: Advantages, Limitations, and Effect. Mayo Clin Proc 1994; 69: 44-49). (Pubitemid 24016915)
5. Burch HB. Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am 1995; 24: 663-710.
6. Giuffrida D, Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 1995; 99: 642-50. (Pubitemid 26006446)
7. Haber RS. Thyroid Nodules and the Detection of Thyroid Cancer. Mount Sinai J Med 1996; 63: 10-15. (Pubitemid 126575870)
8. Meier CA. Molekulare Endokrinologie von Schilddrüsenkrankheiten. Schweiz Med Wschr 1995; 125: 2367-78.
9. Grebe StKG, Hay ID: Follicular cell-derived thyroid carcinomas.In: Endocrine Neoplasms. A. Arnold editor. Cancer Treat Res 1997; 89: 91-140.
10. Goretzki PE. Studies of oncogenes and tumor-suppressor genes in human thyroid carcinomas, and their clinical implications. Langenbeck's Arch Surg 1999; 384: 1-8. (Pubitemid 29225311)
11. DeGroot LJ. Long-Term Impact of Initial and Surgical Therapy on Papillary and Follicular Thyroid Cancer. Am J Med 1994; 97: 499-500. (Pubitemid 24370878)
12. Pasieka JL, Rotstein LE. Consensus Conference on Well-Differentiated Thyroid Cancer: a Summary. Can J Surg 1993; 36: 298-301. (Pubitemid 23302265)
13. Dulgeroff AJ, Hershman JM. Medical therapy of differentiated thyroid carcinoma. Endocrine Reviews 1994; 15: 500-515. (Pubitemid 24271241)
14. McHenry C, Jarosz H, Davis M, Barbato AL, Lawrence AM, Paloyan E. Selective postoperative radioactive iodine treatment of thyroid carcinoma. Surgery 1989; 106: 956-959. (Pubitemid 20012366)
15. McHenry CR, Rosen IB. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991; 162: 353-6.
16. Cady B. Our AMES is true : How an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 1997; 174: 462-468. (Pubitemid 27486004)
17. Gemsenjäger E, Heitz PhU, Martina B. Selective treatment of differentiated thyroid carcinoma. World J Surg 1997; 21: 546-52. (Pubitemid 27235599)
18. Loree TR. Therapeutic implications of prognostic factors in differentiated carcinoma of the thyroid gland. Seminars in Surgical Oncology 1995; 11: 246-255.
19. Shaha AR, Shah JP, Loree TR. Low-Risk Differentiated Thyroid Cancer: The Need für Selective Treatment. Ann Surg Oncol 1997; 4: 328-333. (Pubitemid 127725237)
20. Van Heerden JA. What's New in Endocrine Surgery. J Am Coll Surg 1998; 186: 141-148.
21. Schlumberger MJ. Papillary and Follicular Thyroid Carcinoma. N Engl J Med 1998; 338: 297-306. (Pubitemid 28065257)
22. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A national cancer data base report on 53, 856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998; 83: 2638-2648. (Pubitemid 29019586)
23. Gemsenjäger E, Heitz PhU, Martina B. Prospektive Therapiestudie bei differenziertem Schilddrüsenkarzinom. Schweiz Med Wochenschr 1995; 125: 2226-2236.
24. Gemsenjäger E, Schweizer I. Kleine Schilddrüsenkarzinome: Besonderheiten der Biologie, Diagnostik und Therapie. Schweiz Med Wochenschr 1999; 126: 681-90. (Pubitemid 29226173)
25. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19: 545-76. (Pubitemid 20282656)
26. Cooper DS, Schneyder CR. Follicular and Hürthle cell carcinoma. Endocrinol Metab Clin North Am 1990; 19: 577-91.
27. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. Cancer 1997; 79: 564-573.
28. Cady B, Rossi R. An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 1988; 104: 947-953. (Pubitemid 19011971)
29. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma. A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102: 1088-1095. (Pubitemid 18010757)
30. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary carcinoma. Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114: 1050-1058. (Pubitemid 24004722)
31. Hay ID et al. Unilateral total lobectomy. Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998; 124: 958-966. (Pubitemid 28555179)
32. UICC: International Union Against Cancer: TNM Classification of Malignant Tumours (4th fully rev. ed.),Hermanek P, Sobin LH, editors. Berlin, Springer-Verlag 1992.
33. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995; 118: 1131-1138.
34. Shaha AR, Loree TR, Shah JP. Intermediate risk group für differentiated carcinoma of thyroid. Surgery 1994; 116: 1036-1041. (Pubitemid 24382163)
35. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987; 14: 315-332.
36. Mazzaferri EL. Treating differentiated thyroid carcinoma: where do we draw the line? (editorial). Mayo Clin Proc 1991; 55: 105-111.
37. Mazzaferri El, Jhiang SM. Long-trem impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97: 418-428. (Pubitemid 24345593)
38. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71: 441-24.
39. DeGroot LJ, Kaplan EL, Shukla MS, Salti G, Straus FH. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 1995; 80: 2946-50.
40. WHO: International Histological Classification of Tumors, Hedinger CHR, in collaboration with Williams ED, Sobin LH, editors. Berlin, Springer-Verlag 1988.
41. Van Heerden JA, Hay ID, Goellner JR, Salomao D, Ebersold JR, Bergstralh EJ, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 1992; 112: 1130-8.
42. Schauer A. Pathologie der Schilddrüsentumoren. In: Becker HD, Heinze HG, Herausgeber. Maligne Schilddrüsentumoren. Berlin, Heidelberg: Springer-Verlag; 1984. S. 8-47.
43. Buhr HJ, Mann B. Thyreoidektomie und Lymphadenektomie. Chirurg 1999; 70: 987-998.
44. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma. Is extent of surgical resection important? Surgery 1988; 104: 945-961.
45. Scheumann G FW, Gimm O, Wegener G, Hundeshagen H. Prognostic Significance and Surgical Management of Locorgional Lymph Node Metastases in Papillary Thyroid Cancer. World J Surg 1994; 18: 559-568. (Pubitemid 24273857)
46. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994; 18: 123-130. (Pubitemid 24100703)
47. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992; 112: 1139-47. (Pubitemid 23008243)
48. Rosen IB, Bowden J, Luk SC, Simpson JA. Aggressive thyroid cancer in low- risk age population. Surgery 1987; 102: 1075-1080. (Pubitemid 18010755)
49. Allo MD, Christianson W, Koivunen D. Not all «occult» papillary carcinomas are «minimal». Surgery 1988; 104: 971-976. (Pubitemid 19011974)
50. Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br J Surg 1996; 83: 1674-1683. (Pubitemid 26421859)
51. Sugitani I, Yanagisawa A, Shimizu A, Kato M, Fujimoto Y. Clinicopathologic and Immunohistochemical Studies of Papillary Thyroid Microcarcinoma Presenting with Cervical Lymphadenopathy. World J Surg 1998; 22: 731-737. (Pubitemid 28277870)
52. Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant Metastases in Papillary Thyroid Carcinoma: 100 Cases Observed at One Institution during 5 Decades. J Clin Endocrinol Metab 1995; 80: 2041-2045.
53. Harwood J, Clark OH, Dunphy JE. Significance of Lymph Node Metastasis in Differentiated Thyroid Cancer. Am J Surgery 1978; 136:107-112.
54. Snyder J, Gorman C, Scanlon P. Thyroid remnant ablation: Questionable pursuit of an ill-defined goal. J Nucl Med 1983; 24: 659-665. (Pubitemid 13016085)
55. Tisell LE, Nilsson B, Mölne J, Hansson G, Fjälling M,Jansson S, Wingren U. Improved Survival of Patients with Papillary Thyroid Cancer after Surgical Microdissection. World J Surg 1996; 20: 854-859. (Pubitemid 26281914)
56. Noguchi S, Murakami N, Kawamoto H. Classification of Papillary Cancer of the Thyroid Based on Prognosis. World J Surg 1994; 18: 552-558. (Pubitemid 24273856)
57. Noguchi S, Noguchi A, Murakami N. Papillary Carcinoma of the Thyroid. II. Value of Prophylactic Lymph Node Excision. Cancer 1970; 26: 1061-1068.
58. Nilsson B, Jansson S, Mölne J, Nilsson O, Tisell LE. Long Term Continuous Follow-up in Papillary Thyroid Cancer: Locoregional Recurrences and Prognosis. 38th World Congress of Surgery, 1999. Abstract No 004.
59. Grant CS. Invited Commentary. World J Surg 1996; 20: 866.
60. Soh EY, Clark OH. Surgical considerations and approach to thyroid cancer. Endocrinology and Metabolism Clinics North Am 1996; 25: 115-137.
61. Attie JN, Khafif RA, Steckler RM. Elective Neck Dissection in Papillary Carcinoma of the Thyroid. Am J Surg 1971; 122: 464-471.
62. Dralle H, Grimm O. Lymphadenektomie beim Schilddrüsencarcinom. Chirurg 1996; 67: 788-806.
63. Gemsenjäger E. Zur Operationstechnik bei Eingriffen an der Schilddrüse. Chirurg 1993; 64: 725-31. (Pubitemid 23308401)
64. Gemsenjäger E, Schweizer I. Zuckerkandl's Tuberculum in Thyroid Surgery. J Am Coll Surg 1999; 188: 336-337.
65. Woolner LB, Beahrs OH, Black BM, McConahey WM, Keating FR. Classification and prognosis of thyroid carcinoma. Am J Surg 1961; 102: 354-388.
66. Woolner LB. Thyroid carcinoma: Pathologic classification with data on prognosis. Sem Nucl Med 1971; 1: 481-502.
67. Gemsenjäger E. Zur Strumachirurgie von Kocher bis heute. Schweiz Med Wochenschr 1993; 123: 207-213. (Pubitemid 23055687)
68. Bürgi H, Supersaxo Z, Selz B. Iodine deficiency diseases in Switzerland one hundred years after Theodor Kocher's survey: A historical review with some new goitre prevalence data. Acta Endocrinologica (Copenh) 1990; 123:577-590.
69. Kopp P, Kimura ET, Aeschimann S, Oestreicher M, Tobler A, Frey MF, Studer H. Polyclonal and Monoclonal Thyroid Nodules Coexist within Human Multinodular Goiters. J Clin Endocrinol Metab 1994;1: 134-139. (Pubitemid 24221172)
70. Heitz PhU, Moser HR, Staub JJ. Thyroid Cancer: A Study of 573 Thyroid Tumors and 161 Autopsy Cases Observed over a Thirty-Year Peroid. Cancer 1976; 37: 2329-2337.
71. Gemsenjäger E. Die chirurgische Behandlung der autonomen Knotenstruma. Schweiz Med Wochenschr 1992; 122: 687-692.
72. Baltisberger BL, Minder ChE, Bürgi H. Decrease of incidence of toxic nodular goiter in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrin 1995; 132: 546-549.
73. Reeve TS, Delbridge L, Cohen A, Crummer P: Total thyroidectomy: The preferred option for multinodular goitre. Ann Surg 1987; 206: 782-786.
74. Khadra M, Delbridge L, Reeve TS, Polle AG; Crummer P: Total thyroidectomy: Its role in the management of thyroid disease. Aust N Z J Surg 1992; 62: 91-95.
75. Chen H, Zeiger MA, Clark DP, Westra WH, Udelsman R. Papillary carcinoma of the thyroid: Can operative management be based solely on fine-needle aspiration? J Am Coll Surg 1997; 184: 605-610. (Pubitemid 27255220)
76. Boyd LA, Earnhardt RC, Dunn JT, Frierson HF, Hanks JB. Preoperative Evaluation and Predictive Value of Fine-Needle Aspiration and Frozen Section of Thyroid Nodules. J Am Coll Surg 1998; 187: 494-502. (Pubitemid 28506855)
77. Chen H, Nicol THL, Udelsman R. Follicular Lesions of the Thyroid. Does Frozen Section Evaluation Alter Operative Management? Ann Surg 1995; 222: 101-106.
78. Kukkonen ST, Haapiainen RK, Franssila KO, Sivula AH. Papillary thyroid carcinoma: The new, age-related TNM classification system in a retrospective analysis of 199 patients. World J Surg 1990; 14: 837-842.
79. Salvesen H, Njolstad PR, Akslen LA, Albrektsen G, Soreide O, Varhaug JE. Papillary Thyroid Carcinoma: A Multivariate Analysis of Prognostic Factors Including an Evaluation of the p-TNM Staging System. Eur J Surg 1992; 158: 583-589. (Pubitemid 23025711)
80. Simon D, Goretzki PE, Witte J, Röher HD. Incidence of Regional Recurrence Guiding Radicality in Differentiated Thyroid Carcinoma. World J Surg 1996; 20: 860-866. (Pubitemid 26281915)
81. Hermanek P. Will- Rogers- Phänomen-Fakt oder Fiktion? Chirurg 1996; 67: 769-770.
82. Gemsenjäger E, Gyr K. Comment. Pros and Cons. Surg Gynecol Obstet 1983; 157: 367-368.
83. Clark OH. Invited Commentary. World J Surg 1999; 23: 773-774.
84. Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 1998; 85: 252-254. (Pubitemid 28099952)
85. Mirallié E, Visset J, Sagan C, Hamy A, Le Bodic MF, Paineau J. Localization of Cervical Node Metastasis of Papillary Thyroid Carcinoma. World J Surg 1999; 23: 970-974. (Pubitemid 29398483)
86. Muth A, Mölne J, Tisell LE, Ahlman H, Nilsson O, Jansson S, Wangberg B. Correlation of Fine Needle Aspiration Cytology and Surgical Findings in Follicular Neoplasia. 38th World Congress of Surgery, 1999. Abstract No 248.
87. Foster R.S. Morbidity and mortality after thyroidectomy. Surg Gynecol Obstet 1978; 146: 423-426.
88. Reeve TS: Total thyroidectomy. Aust N Z J Surg 1992; 62: 90.
89. ReeveTS, Curtin A, Fingleton L, Kennedy P, Mackie W, Porter T, Simons D, Towned D, Delbridge L. Can Total Thyroidectomy Be Performed as Safely by General Surgeons in Provincial Centers as by Surgeons in Specialized Endocrine Surgical Units? Making the Case for Surgical Training. Arch Surg 1994; 129: 834-836. (Pubitemid 24249138)
90. Gemsenjäger E, Schweizer I. Kapseldissektion bei Thyreoidektomie. Video 1999.
91. Paloyan E et al: Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer. Surgical Oncology Clinics of North America 1998; 7: 665-680. (Pubitemid 28436534)
92. Gemsenjäger E. Die Chirurgie des Rektumkarzinoms: Eine Standortbestimmung. Schweiz Med Wochenschr 1998; 128: 416-426. (Pubitemid 28102859)